TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer
Clinical trial NCT02988986 · COMPLETED
Trial details
- NCT number
- NCT02988986
- Sponsor
- The Methodist Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2019-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.